Biologic therapies in type 2 asthma: mechanisms, clinical evidence, and impact in high-altitude populations
Abstract Asthma is a common chronic airway disease, and type 2 asthma is typically characterised by eosinophilic airway inflammation and a suboptimal response to conventional therapies. The advent of biologic agents has driven a paradigm shift towards precision medicine in asthma management. However...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SpringerOpen
2026-03-01
|
| Series: | The Egyptian Journal of Bronchology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s43168-026-00546-y |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|